Hepatitis C: A Silent, Deadly Disease: Treatment Beyond Reach of Most Indians

Every year, July 28 is remembered as the ‘World Hepatitis Day’. In India, this year too, the day had gone by virtually uneventful, for various reasons. This happened despite increasing trend of the disease in the country. Though, there are … Continue reading

Pharma industry requires striking a right balance between ethical obligations to shareholders and ethical obligations to patients

On September 15, 2012, while delivering his keynote address in a pharmaceutical industry function, Dr. Sam Pitroda, the Chicago based Indian, creator of the telecom revolution in India and the Advisor to the Prime Minister on Public Information, Infrastructure & … Continue reading

The New Drug Policy of India enters into the final lap of a Marathon Run

Final working out and thereafter announcement of much awaited and long overdue the new ‘Drug Policy’ of India has now entered into a very interesting stage. This is mainly because of the unique combination of the following three key reasons: … Continue reading

The New Drug Policy is languishing in a labyrinth

Drug Price Control has remained the key feature of all Drug Policies of India, since their inception in early 70’s. Most of these policies continued to remain behind their times consistently, without any exception. That said, the Drug Policy 1994 … Continue reading

Getting unfolded a global opportunity for India with Biosimilar Drugs

Over a period of time, the trend of a disease treatment process is becoming more targeted and personalized to improve effectiveness of both diagnosis and treatment. Biotechnology being the key driver to this trend, India should not fall out of … Continue reading

Health being a basic human right, the proposal for ‘Universal Health Coverage’ augurs well for India

“The right to health is relevant to all States: every State has ratified at least one international human rights treaty recognizing the right to health. Moreover, States have committed themselves to protecting this right through international declarations, domestic legislation and … Continue reading

From Cross-Licensing to ‘Patent Pools’ and… India: Will there be a ground swell?

Since many years, the global pharmaceutical industry has been making effective commercial use of cross-licensing, however, by and large, the industry still does not seem to be quite in favor of  ‘Patent Pools’ for various reasons. The ‘Patent Pool’, as … Continue reading

Biologic Medicine: Ushers in a different ‘Mega Race’ for inorganic growth

During the last several years the success of biologics compared to conventional small-molecule drugs to meet the unmet needs of patients, is gradually but surely changing the area of focus of pharmaceutical R&D altogether, making the biotech companies interesting targets … Continue reading